1. Home
  2. EOLS vs HSTM Comparison

EOLS vs HSTM Comparison

Compare EOLS & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • HSTM
  • Stock Information
  • Founded
  • EOLS 2012
  • HSTM 1990
  • Country
  • EOLS United States
  • HSTM United States
  • Employees
  • EOLS N/A
  • HSTM N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • HSTM Computer Software: Programming Data Processing
  • Sector
  • EOLS Health Care
  • HSTM Technology
  • Exchange
  • EOLS Nasdaq
  • HSTM Nasdaq
  • Market Cap
  • EOLS 854.0M
  • HSTM 960.2M
  • IPO Year
  • EOLS 2018
  • HSTM 2000
  • Fundamental
  • Price
  • EOLS $12.05
  • HSTM $32.03
  • Analyst Decision
  • EOLS Strong Buy
  • HSTM Hold
  • Analyst Count
  • EOLS 4
  • HSTM 2
  • Target Price
  • EOLS $24.67
  • HSTM $30.00
  • AVG Volume (30 Days)
  • EOLS 736.2K
  • HSTM 192.4K
  • Earning Date
  • EOLS 03-04-2025
  • HSTM 04-21-2025
  • Dividend Yield
  • EOLS N/A
  • HSTM 0.39%
  • EPS Growth
  • EOLS N/A
  • HSTM 32.31
  • EPS
  • EOLS N/A
  • HSTM 0.66
  • Revenue
  • EOLS $266,274,000.00
  • HSTM $291,646,000.00
  • Revenue This Year
  • EOLS $34.56
  • HSTM $6.51
  • Revenue Next Year
  • EOLS $32.26
  • HSTM $5.69
  • P/E Ratio
  • EOLS N/A
  • HSTM $48.65
  • Revenue Growth
  • EOLS 31.76
  • HSTM 4.51
  • 52 Week Low
  • EOLS $9.25
  • HSTM $23.92
  • 52 Week High
  • EOLS $17.82
  • HSTM $34.24
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.35
  • HSTM 48.65
  • Support Level
  • EOLS $13.07
  • HSTM $31.60
  • Resistance Level
  • EOLS $13.66
  • HSTM $32.27
  • Average True Range (ATR)
  • EOLS 0.58
  • HSTM 0.80
  • MACD
  • EOLS -0.15
  • HSTM 0.07
  • Stochastic Oscillator
  • EOLS 22.22
  • HSTM 79.07

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About HSTM HealthStream Inc.

HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.

Share on Social Networks: